Activation of both adenosine A2A and A2B receptors (A2BR) contributes to coronary vasodilation. We previously demonstrated that uridine adenosine tetraphosphate (Up4A) is a novel vasodilator in the porcine coronary microcirculation, acting mainly on A2AR in smooth muscle cells (SMC). We further investigated whether activation of A2BR is involved in Up4A-mediated coronary SMC relaxation. Both A2AR and A2BR may stimulate H2O2 production leading to activation of KATP channels in SMCs, we also studied the involvement of H2O2 and KATP channels in Up4A-mediated effect. Coronary small arteries dissected from the apex of porcine hearts were mounted on wire myograph for Up4A concentration responses. Up4A-induced coronary SMC relaxation was attenuate...
Uridine adenosine tetraphosphate (Up4A), a novel endothelium-derived vasoactive agent, is proposed t...
Previously, we have shown that A2A adenosine receptor (A2AAR) mediates aortic relaxation via cytochr...
Introduction: The P2Y14 receptor, with its unique pharmacologic profile, is the only member of its P...
Activation of both adenosine A2A and A2B receptors (A2BR) contributes to coronary vasodilation. We p...
Uridine adenosine tetraphosphate (Up4A) has been identified as an endothelium-derived contracting fa...
Myocardial metabolites such as adenosine mediate reactive hyperemia, in part, by activating ATP-depe...
Plasma levels of the vasoactive substance uridine adenosine tetraphosphate (Up4A) are elevated in hy...
Adenosine is a potent vasodilator that plays an important role in the regulation of coronary microva...
We previously demonstrated that uridine adenosine tetraphosphate (Up(4)A) induces potent and partial...
Uridine adenosine tetraphosphate (Up4A) exerts potent relaxation in porcine coronary arteries that i...
Adenosine plays a role in physiological and pathological conditions, and A2 adenosine receptor (AR) ...
We have previously demonstrated that adenosine-mediated H2O2 production and opening of ATP-sensitive...
One out of three individuals suffer from one form of cardiovascular disease, out of which, about 6,0...
Adenosine increases coronary flow mainly through the activation of A2A and A2B adenosine receptors (...
Aims\ud \ud UDP-sugars can act as extracellular signalling molecules, but relatively little is known...
Uridine adenosine tetraphosphate (Up4A), a novel endothelium-derived vasoactive agent, is proposed t...
Previously, we have shown that A2A adenosine receptor (A2AAR) mediates aortic relaxation via cytochr...
Introduction: The P2Y14 receptor, with its unique pharmacologic profile, is the only member of its P...
Activation of both adenosine A2A and A2B receptors (A2BR) contributes to coronary vasodilation. We p...
Uridine adenosine tetraphosphate (Up4A) has been identified as an endothelium-derived contracting fa...
Myocardial metabolites such as adenosine mediate reactive hyperemia, in part, by activating ATP-depe...
Plasma levels of the vasoactive substance uridine adenosine tetraphosphate (Up4A) are elevated in hy...
Adenosine is a potent vasodilator that plays an important role in the regulation of coronary microva...
We previously demonstrated that uridine adenosine tetraphosphate (Up(4)A) induces potent and partial...
Uridine adenosine tetraphosphate (Up4A) exerts potent relaxation in porcine coronary arteries that i...
Adenosine plays a role in physiological and pathological conditions, and A2 adenosine receptor (AR) ...
We have previously demonstrated that adenosine-mediated H2O2 production and opening of ATP-sensitive...
One out of three individuals suffer from one form of cardiovascular disease, out of which, about 6,0...
Adenosine increases coronary flow mainly through the activation of A2A and A2B adenosine receptors (...
Aims\ud \ud UDP-sugars can act as extracellular signalling molecules, but relatively little is known...
Uridine adenosine tetraphosphate (Up4A), a novel endothelium-derived vasoactive agent, is proposed t...
Previously, we have shown that A2A adenosine receptor (A2AAR) mediates aortic relaxation via cytochr...
Introduction: The P2Y14 receptor, with its unique pharmacologic profile, is the only member of its P...